Invention Grant
- Patent Title: E2F as a target of hormone refractory prostate cancer
- Patent Title (中): E2F作为激素难治性前列腺癌的靶标
-
Application No.: US14474595Application Date: 2014-09-02
-
Publication No.: US09314497B2Publication Date: 2016-04-19
- Inventor: Joseph R. Bertino , Debabrata Banerjee , Tamara Minko , Olga B. Garbuzenko , Xiaoqi Xie , John E. Kerrigan , Emine E. Abali , Kathleen W. Scotto
- Applicant: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
- Applicant Address: US NJ New Brunswick
- Assignee: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
- Current Assignee: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
- Current Assignee Address: US NJ New Brunswick
- Agency: Fox Rothschild LLP
- Main IPC: A61K38/08
- IPC: A61K38/08 ; A61K9/127 ; A61K38/16 ; A61K31/4436 ; A61K31/513 ; A61K31/519 ; A61K45/06 ; C07K14/47
Abstract:
The instant invention provides amino acid sequences competing with E2F for DNA binding. Methods of using said amino acid sequences for treatment of hormone-refractory prostate cancer are also provided.
Public/Granted literature
- US20150202248A1 E2F AS A TARGET OF HORMONE REFRACTORY PROSTATE CANCER Public/Granted day:2015-07-23
Information query
IPC分类:
